Insider Transactions in Q3 2024 at Selecta Biosciences Inc (SELB)
Insider Transaction List (Q3 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 25
2024
|
Timothy A Springer Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
722,668
+15.33%
|
-
|
|
Sep 25
2024
|
Timothy A Springer Director |
SELL
Exercise of conversion of derivative security
|
Indirect |
722,668
-100.0%
|
-
|
|
Sep 25
2024
|
Timothy A Springer Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,636,832
+21.39%
|
-
|
|
Sep 25
2024
|
Timothy A Springer Director |
SELL
Exercise of conversion of derivative security
|
Direct |
1,636,832
-100.0%
|
-
|
|
Aug 12
2024
|
Timothy C Barabe Director |
BUY
Open market or private purchase
|
Direct |
7,500
+25.63%
|
$90,000
$12.7 P/Share
|
|
Aug 12
2024
|
Timothy A Springer Director |
BUY
Open market or private purchase
|
Indirect |
8,016
+41.06%
|
$96,192
$12.72 P/Share
|
|
Jul 02
2024
|
Timothy A Springer Director |
BUY
Grant, award, or other acquisition
|
Indirect |
722,668
+50.0%
|
$14,453,360
$20.0 P/Share
|
|
Jul 02
2024
|
Timothy A Springer Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,636,832
+50.0%
|
$32,736,640
$20.0 P/Share
|
|
Jul 01
2024
|
Kemal Malik Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,933
+50.0%
|
-
|